Quercitrin improved cognitive impairment through inhibiting inflammation induced by microglia in Alzheimer's disease mice

Neuroreport. 2022 May 18;33(8):327-335. doi: 10.1097/WNR.0000000000001783. Epub 2022 Apr 8.

Abstract

Objective: Diets rich in quercitrin show a neuroprotective effect, but the mechanism is not very clear at present. The objective of this study is to explore the effect and mechanism of quercitrin in the treatment of alzheimer's disease (AD).

Methods: 5XFAD transgenic mice were fed with a diet supplemented with quercitrin for three consecutive months. Behavioral experiments were conducted to assess the cognitive ability, luminex liquid chip technology was used to assess the production of proinflammatory cytokines and immunohistochemistry was used to elucidate the activation of microglia.

Results: Quercitrin increased the frequency in exploring new objects, shortened the escape latency and increased the frequency crossing the platform in AD model mice. Quercitrin inhibited the activation and proliferation of microglia, inhibited the secretion of inflammatory cytokines and chemokines and reduced the accumulation of amyloid-β plaques in AD model mice.

Conclusion: Quercitrin improved mice cognitive impairment through alleviating the intensity of inflammatory response and is a promising medicinal plant extract in the treatment of AD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / drug therapy
  • Amyloid beta-Peptides / pharmacology
  • Animals
  • Cognitive Dysfunction* / drug therapy
  • Cytokines
  • Disease Models, Animal
  • Inflammation* / drug therapy
  • Mice
  • Mice, Transgenic
  • Microglia / metabolism
  • Quercetin* / analogs & derivatives
  • Quercetin* / therapeutic use

Substances

  • Amyloid beta-Peptides
  • Cytokines
  • quercitrin
  • Quercetin